Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Massimo Bonucci | Medicine and Dentistry | Best Researcher Award

Humanitas Consortium University - ARTOI Foundation | Italy

Prof. Dr. Massimo Bonucci is a distinguished researcher whose scholarly contributions span integrative oncology, cancer therapeutics, and complementary medical approaches. With 153 citations from 153 documents, 20 published documents, and an h-index of 8, his scientific work reflects a growing influence in evidence-based integrative cancer research. His publications demonstrate a strong focus on combining conventional oncology with complementary modalities to enhance patient outcomes, as seen in studies addressing glioblastoma survival, integrative management of myeloproliferative neoplasms, and the synergistic effects of natural compounds such as curcumin, polydatin, and epigallocatechin gallate. His research portfolio includes influential articles in journals such as Journal of Clinical Medicine, Cancers, Onco, Journal of Integrative and Complementary Medicine, and the International Journal of Integrative Oncology, covering topics from locoregional hyperthermia to hematologic diseases, qualitative patient-care insights, and global initiatives in integrative oncology. Recent works explore advancements in dietary supplements, hyperthermia applications, patient-centered care strategies, and international collaborations within the integrative oncology community. Through his continuous contributions and multidisciplinary perspective, Prof. Dr. Bonucci has helped expand the scientific foundation of integrative oncology, supporting its development as a complementary framework within modern cancer research.

Profiles : Scopus | Orcid

Featured Publications

Andreazzoli, F., Yurkovski, I. L., Gowin, K., & Bonucci, M. (2025). Management of myeloproliferative neoplasms: An integrative approach. Journal of Clinical Medicine.

Bonucci, M., Fuggetta, M. P., Anelli, L., Giannarelli, D., Fiorentini, C., & Ravagnan, G. (2025). New approach for enhancing survival in glioblastoma patients: A longitudinal pilot study on integrative oncology. Cancers.

Fiorentini, G., Sarti, D., Mambrini, A., Mattioli, G., Bonucci, M., Ginocchi, L., Cristina, G., Ranieri, G., Bonanno, S., Milandri, C., et al. (2025). Locoregional hyperthermia in cancer treatment: A narrative review with updates and perspectives. Onco.

Bonucci, M. (2025). Superior oral bioavailability of epigallocatechin gallate from TèPigal 300®, a dietary supplement versus a cup of green tea. Journal of Clinical Medical Research.

Stylianou, K., Fuller-Shavel, N., Ghelman, R., Ben-Arye, E., Bonucci, M., Jia, L., Narayanan, S., & Rao, S. (2025). Bridging borders in integrative oncology: A global initiative by the Society for Integrative Oncology. Journal of Integrative and Complementary Medicine.

Bonucci, M. (2025). Introduction to hematologic diseases and integrative therapies: The use of natural supplements and complementary therapies with clinical and preclinical evidence. Figshare.

Chiarlone, P. (2024). Words are life: Written memories in the hospice experience—A qualitative study. International Journal of Integrative Oncology.

Serafino, A., Krasnowska, E. K., Romanò, S., De Gregorio, A., Colone, M., Dupuis, M. L., Bonucci, M., Ravagnan, G., Stringaro, A., & Fuggetta, M. P. (2024). The synergistic combination of curcumin and polydatin improves temozolomide efficacy on glioblastoma cells. International Journal of Molecular Sciences.

Mazzotti, E. (2024). Physical activity in the treatment of cancer patients: An online survey for Italian oncologists and radiotherapists. International Journal of Integrative Oncology.

Mazzotti, E. (2024). Letter to editor on: A feasibility study for the acceptability of virtual reality for patients with cancer undergoing treatment. International Journal of Integrative Oncology.

Cracolici, F. (2024). Improving the quality of life of breast cancer patients with integrated medicine techniques. International Journal of Integrative Oncology.

Anelli, L. (2024). Case report of possible abscopal effect in a patient with metastatic bladder cancer treated with radiotherapy and Artemisia compounds. International Journal of Integrative Oncology.

Andrea Sonaglioni | Medicine and Dentistry | Best Researcher Award

Dr. Andrea Sonaglioni | Medicine and Dentistry | Best Researcher Award

MultiMedica IRCCS | Italy

Dr. Andrea Sonaglioni is a distinguished cardiologist and medical researcher recognized for his extensive contributions to cardiovascular imaging and clinical cardiology. Serving as Medical Director of the Echocardiography Unit at the San Giuseppe Hospital, MultiMedica S.p.A. in Milan, he has developed deep expertise in non-invasive cardiovascular diagnostics, including transthoracic, transesophageal, and stress echocardiography. His research interests span cardio-oncology, cardio-obstetrics, pulmonary hypertension, and cardiac mechanics, with an emphasis on translational and imaging-based studies. Dr. Sonaglioni has authored 112 scientific publications in high-impact international journals, with his works cited 988 times by 674 documents, reflecting his strong influence in the field. He maintains an h-index of 20, underscoring the lasting significance of his research. In addition to his investigative and clinical achievements, he serves as a reviewer for leading cardiovascular journals and has presented numerous papers at national and international conferences. His ongoing projects, including the CARTOX-PREDICT study on cardiotoxicity in cancer therapy, exemplify his commitment to advancing patient-centered cardiovascular care and integrating innovative diagnostic methodologies into clinical practice.

Profiles : Scopus | Orcid

Featured Publications

Sonaglioni, A., & Nicolosi, G. L. (2025). A paradox within the paradox: Beyond body composition indices, waist circumference, and non-radiological anteroposterior thoracic diameter as predictors of subclinical myocardial dysfunction in obesity. Echocardiography.

Sonaglioni, A., Nicolosi, G. L., Bruno, A., & Lombardo, M. (2025). Accuracy of noninvasive screening exercise tests for detecting coronary artery disease in symptomatic patients with mitral valve prolapse: A systematic review. Journal of Cardiovascular Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Lombardo, M., & Muti, P. (2025). Could pulsed wave tissue Doppler imaging solve the diagnostic dilemma of right atrial masses and pseudomasses? A case series and literature review. Journal of Clinical Medicine.

Sonaglioni, A., Bruno, A., Nicolosi, G. L., Fossile, E., Rubuano, C., Ricotta, R., Gemelli, M., Lombardo, M., Muti, P., & Bassani, B. (2025). Effect of immune checkpoint inhibitor therapy on biventricular mechanics in cancer patients over a short-term follow-up: A systematic review. Frontiers in Immunology.

Sonaglioni, A., & Nicolosi, G. L. (2025). Is there only cardiac mechanics pathophysiology behind echocardiographic global longitudinal strain and twisting algorithms? International Journal of Cardiology.

Sonaglioni, A., Nicolosi, G. L., & Lombardo, M. (2025). Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis. International Journal of Cardiology.

Sonaglioni, A., & Nicolosi, G. L. (2025). Three-dimensional left atrial strain in hypertensive disorders of pregnancy: A new prognostic frontier? Echocardiography.

Sonaglioni, A., Polymeropoulos, A., Baravelli, M., Nicolosi, G. L., Lombardo, M., & Biondi-Zoccai, G. (2025). Diagnostic accuracy of exercise stress testing, stress echocardiography, myocardial scintigraphy, and cardiac magnetic resonance for obstructive coronary artery disease: Systematic reviews and meta-analyses of 104 studies published from 1990 to 2025. Journal of Clinical Medicine.

Sonaglioni, A., Napoli, F., Dell’Anna, R., Nicolosi, G. L., Bianchi, S., Lombardo, M., Harari, S., & Lonati, C. (2025). Comprehensive assessment of biventricular and biatrial myocardial strain parameters at six years postpartum in a cohort of women with previous hypertensive disorders of pregnancy. Journal of Clinical Medicine.

Sonaglioni, A., Baravelli, M., Caminati, A., Tagariello, F., De Cesco, F., Nicolosi, G. L., Lombardo, M., & Harari, S. (2025). Effect of chronic obstructive pulmonary disease (COPD) on biventricular mechanics in patients without severe airflow obstruction. Journal of Clinical Medicine.

Sonaglioni, A., Cerini, F., Fagiani, V., Nicolosi, G. L., Rumi, M. G., Lombardo, M., & Muti, P. (2025). Effect of metabolic dysfunction-associated steatotic liver disease (MASLD) on left ventricular mechanics in patients without overt cardiac disease: A systematic review and meta-analysis. Journal of Clinical Medicine.

Sonaglioni, A., Lucidi, A., Luisi, F., Caminati, A., Nicolosi, G. L., Rispoli, G. A., Zompatori, M., Lombardo, M., & Harari, S. (2025). A dynamic multimodality imaging assessment of right ventricular thrombosis in a middle-aged man with lymphocytic interstitial pneumonia: The additive role of tissue Doppler imaging. Journal of Clinical Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Rispoli, G. A., Lombardo, M., & Muti, P. (2025). Does preliminary chest shape assessment improve the prognostic risk stratification of individuals with mitral annular disjunction? A case report and narrative review. Journal of Clinical Medicine.

Sonaglioni, A., Casieri, F., Nicolosi, G. L., Bianchi, S., & Lombardo, M. (2025). Comprehensive assessment of biventricular and biatrial myocardial strain parameters at four years postpartum in a cohort of women with previous gestational diabetes mellitus. Journal of Clinical Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Polymeropoulos, A., Lombardo, M., & Muti, P. (2025). Echocardiographic assessment of cardiac structure and function of centenarians: A systematic review. Geriatrics.

Sonaglioni, A., Caminati, A., Behring, G., Nicolosi, G. L., Rispoli, G. A., Zompatori, M., Lombardo, M., & Harari, S. (2025). Prognostic role and determinants of ascending aorta dilatation in non-advanced idiopathic pulmonary fibrosis: A preliminary observation from a tertiary university center. Journal of Clinical Medicine.

Sonaglioni, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Lombardo, M., & Muti, P. (2025). The prevalence, pathophysiological role and determinants of mitral annular disjunction among patients with mitral valve prolapse: A systematic review. Journal of Clinical Medicine.

Sonaglioni, A., Caminati, A., Nicolosi, G. L., Muti-Schünemann, G. E. U., Lombardo, M., & Harari, S. (2025). Echocardiographic assessment of biventricular mechanics in patients with mild-to-moderate idiopathic pulmonary fibrosis: A systematic review and meta-analysis. Journal of Clinical Medicine.

 

Best Innovator Award

Introduction

The Best Innovator Award is a distinguished recognition designed to honor individuals who have demonstrated exceptional creativity, ingenuity, and impact through groundbreaking innovations. Innovation drives progress across various fields, and this award acknowledges those who have significantly contributed to technological advancements, scientific breakthroughs, or transformative ideas. By recognizing outstanding innovators, the award aims to foster a culture of creativity, problem-solving, and forward-thinking approaches that shape the future of industries and societies.

Award Overview

The Best Innovator Award is conferred annually to individuals or teams who have developed groundbreaking innovations that demonstrate originality, feasibility, and societal impact. The award spans multiple disciplines, including science, engineering, medicine, information technology, business, and social entrepreneurship. It serves as a platform to showcase pioneering work, highlighting the importance of innovation in driving progress and addressing global challenges. The award not only honors past achievements but also encourages continued exploration and development of new ideas that have the potential to create a lasting impact on the world.

Eligibility

The Best Innovator Award is open to individuals, research teams, startups, and organizations that have introduced an innovation with a demonstrable impact. Nominees must provide substantial evidence of their innovation’s success, application, and influence within their field. Both early-career and experienced professionals are eligible, as long as their work showcases significant ingenuity and advancement. Innovations must be original, ethically developed, and capable of being implemented for real-world benefits. The award is open to international applicants, recognizing the global nature of innovation and its widespread impact.

Evaluation Criteria

The selection of the Best Innovator Award is based on a thorough evaluation of the innovation’s originality, significance, and effectiveness. The key criteria include the novelty of the idea, technological or conceptual advancements, practical applications, and societal contributions. Judges assess the problem-solving aspect of the innovation, measuring its effectiveness in addressing critical challenges within its respective field. Market readiness, scalability, and sustainability are also considered, ensuring that the innovation holds long-term potential for industry and community development. The impact of the innovation on improving lives, industries, or research is weighed heavily in the final decision.

Submission Guidelines

Applicants must submit a comprehensive nomination package detailing their innovation, its development process, and its impact. The submission should include a detailed description of the innovation, supporting technical documents, and relevant images or videos demonstrating its functionality. A personal or team biography, outlining the background of the innovator(s) and their journey in developing the innovation, is required. Applicants must provide verifiable data and case studies showcasing the innovation’s effectiveness. Supporting documents such as patents, research publications, testimonials, and industry recognition strengthen the application. The deadline for submissions is strictly enforced, and incomplete applications will not be considered.

Recognition

Winners of the Best Innovator Award receive a prestigious certificate, a trophy commemorating their achievement, and public recognition through press releases, academic journals, and social media. The award provides international exposure, allowing winners to connect with investors, research institutions, and industry leaders. Recipients may be invited to present their innovations at conferences, global summits, and innovation expos. This recognition fosters networking opportunities and potential collaborations that can further develop and scale the innovation. The award also enhances the credibility and career prospects of the winners, opening doors to new funding, research grants, and professional opportunities.

Community Impact

Innovation plays a crucial role in shaping the future of societies and industries, and the Best Innovator Award seeks to highlight innovations that have made a tangible difference. By recognizing groundbreaking work, the award inspires the next generation of thinkers, entrepreneurs, and researchers to push the boundaries of knowledge and technology. The community benefits from exposure to revolutionary ideas that can drive economic growth, improve quality of life, and solve pressing global issues. The award encourages a culture of creativity and collaboration, fostering an environment where innovative solutions thrive and generate meaningful change.

Biography

Applicants must submit a well-documented biography that outlines their academic and professional background, key achievements, and journey in innovation. This section should highlight major milestones, challenges overcome, and the motivation behind their work. The biography should reflect the innovator’s dedication to research, experimentation, and problem-solving. For team applications, details of each member’s role and contributions should be included. The biography provides judges with insights into the passion, perseverance, and expertise of the nominee, helping to contextualize their innovation and its impact.

Abstract

A clear and concise abstract summarizing the nominated innovation is required. This should include the problem statement, objectives, methodology, and key findings. The abstract should also highlight why the innovation is unique and how it contributes to advancements in its field. A well-structured abstract enhances the application by providing a snapshot of the innovation’s significance, enabling the selection committee to assess its merit quickly. Applicants should ensure the abstract is engaging, informative, and reflective of the broader implications of their work.

Supporting Files

To strengthen their submission, applicants should provide relevant supporting materials that verify their innovation’s success and impact. These may include patents, research papers, prototype demonstrations, media coverage, testimonials from industry experts, and letters of endorsement from academic institutions or professional bodies. Videos showcasing the innovation in action, graphical representations, and data-driven analyses further enhance the application. High-quality supporting documents help establish the credibility of the innovation and provide compelling evidence of its effectiveness and significance.

 

 

 

Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Dr. Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Toronto Western Hospital, University of Toronto | Canada

Author Profile

Scopus

📚 Early Academic Pursuits

Dr. Fadi Kharouf's academic journey began with a passion for [his specialization], leading him to pursue rigorous studies in [his major] at [his university]. His early academic years were marked by exceptional dedication, laying the foundation for his future research and professional endeavors.

💼 Professional Endeavors

Dr. Kharouf's career spans across academia and industry, where he has made significant contributions as a [his position] at [his institution/organization]. His expertise in [specific areas of expertise] has led to groundbreaking advancements, positioning him as a key figure in [his field].

🔬 Contributions and Research Focus

With a deep focus on [his primary research areas], Dr. Kharouf has worked extensively on [specific research projects or innovations]. His work on [notable findings or methodologies] has been instrumental in shaping new perspectives in [his domain]. His research has not only expanded theoretical knowledge but also paved the way for practical applications in [relevant industries].

🏅 Accolades and Recognition

Dr. Kharouf's contributions have earned him numerous awards and honors, recognizing his excellence in research and innovation. His work has been published in prestigious journals, and he has been invited as a keynote speaker at major conferences, reflecting his influence and thought leadership.

🌍 Impact and Influence

Beyond academia, Dr. Kharouf's impact extends to mentoring young researchers, collaborating on international projects, and contributing to policy-making in [his field]. His ability to bridge the gap between research and real-world applications has made a lasting impact on [his industry or academic community].

🚀 Legacy and Future Contributions

As Dr. Kharouf continues to push the boundaries of knowledge, his legacy is defined by his commitment to excellence and innovation. His ongoing work promises to further revolutionize [his domain], inspiring future generations to follow in his footsteps.

Publications


  • 📄The association between cigarette smoking and radiographic progression in Psoriatic Arthritis

    • Authors: Fadi Kharouf, Hernán H. Maldonado-Ficco, Shangyi S. Gao, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis

    • Authors: Fadi Kharouf, Pankti P. Mehta, Shangyi S. Gao, Dafna D.D. Gladman, Vinod V. Chandran
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Degenerative Disc Disease In Young Adults With Psoriatic Arthritis

    • Authors: Fadi Kharouf, Shangyi S. Gao, D. Pereira, R.J. Cook, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Journal of Rheumatology
    • Year: 2025

  • 📄Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

    • Authors: Fadi Kharouf, Dafna D.D. Gladman
    • Journal: Current Rheumatology Reviews
    • Year: 2025

  • 📄Lupus nephritis: Biomarkers

    • Authors: C. Dobrowolski, S.M. Lao, Fadi Kharouf, P.P. Croci, J. Wither, D.D. Gladman, L.W. Garcia, A. Jauhal, Z. Touma
    • Journal: Advances in Clinical Chemistry
    • Year: 2025

 

Subhash Chandra Yadav | Health Professions | Best Researcher Award

Prof. Dr. Subhash Chandra Yadav | Health Professions | Best Researcher Award

All India Institute of Medical Sciences, New Delhi | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits 🎓

Prof. Dr. Subhash Chandra Yadav began his academic journey with an MSc in Biotechnology from Banaras Hindu University (BHU), Varanasi, in 2003. His thirst for knowledge led him to pursue a Ph.D. in Molecular Biology at BHU, which he completed in 2007 under the mentorship of Prof. Jagannadham V. Medicherla. His doctoral research focused on "Milin," a highly stable glycosylated dimeric plant serine protease from Euphorbia milii, examining its structure, function, folding, and crystallographic properties. During his academic development, he also gained international exposure as a research trainee at the Institute of Crystallography, Free University (FU) Berlin, Germany, from September 2005 to April 2006, where he honed his skills in protein structural biology.

Professional Endeavors and Milestones 💼

Dr. Yadav's illustrious career spans prestigious institutions globally:

  • Postdoctoral Fellowships: He worked on molecular biophysics at the Indian Institute of Science (IISc), Bangalore, and at the Graduate School of Medicine, University of Tennessee, USA.
  • Research and Leadership Roles: As a Scientist and In-Charge of Nanobiology and Electron Microscopy Facility at CSIR-IHBT, Palampur, and Fellow at TERI-Deakin Nanobiotechnology Centre, he spearheaded cutting-edge research.
  • Academic Excellence: He has been serving All India Institute of Medical Sciences (AIIMS), New Delhi, since 2015, rising to the role of Additional Professor. He was also a Visiting Professor at Stanford University, USA, in 2019-2020.

Contributions and Research Focus 🔬

Dr. Yadav’s research interests are at the confluence of nanotechnology, molecular biology, and microscopy:

  • Electron Microscopy and Cryo-Electron Tomography: Advancing the understanding of cellular structures at atomic resolution.
  • Nano-enabled Diagnostic Tools: Innovating methods for rapid and accurate disease detection.
  • Targeted Drug Delivery Systems: Developing nanoparticles for precise therapeutics.

His work includes over 6,630 citations, with an h-index of 18, reflecting the impact of his research. His patent portfolio includes innovative detection kits, cancer diagnostics, and nanotechnology-based systems.

Accolades and Recognition 🏆

Dr. Yadav's groundbreaking contributions have earned him numerous accolades:

  • 2024: Fellow of the Electron Microscopy Society of India.
  • 2019: Long-Term Fellowship from the Department of Health Research to work at Stanford University.
  • 2018: Excellence in Microscopy Award by the Electron Microscope Society of India.
  • 2005-2006: Boehringer Ingelheim Fonds Fellowship, Germany.

Impact and Influence 🌍

Dr. Yadav has significantly influenced the fields of nanotechnology and microscopy through his teaching, research, and mentorship. As a member of prestigious societies like the Indian Biophysical Society and a reviewer for leading journals, he has contributed to advancing scientific knowledge. His innovative patents and publications continue to inspire advancements in diagnostics and therapeutics.

Legacy and Future Contributions Highlight 🚀

With a career defined by scientific rigor, international collaboration, and a vision for impactful research, Dr. Yadav stands as a beacon of innovation. His ongoing work in nanotechnology and cryo-electron tomography promises to shape the future of medical diagnostics and targeted therapies, leaving a lasting legacy in science and technology.

 

Publications


📄 Magnetic nanoparticles and quantum dots coupled immuno nano fluorescence assay for visual detection of HPV16-induced cervical cancer cells from cytology/biopsy samples
Authors: Raman, S., Tanwar, P., Meena, J., Bhatla, N., Yadav, S.C.
Journal: Sensing and Bio-Sensing Research
Year: 2024


📄 Genetics of 67 patients of suspected primary ciliary dyskinesia from India
Authors: Jat, K.R., Faruq, M., Jindal, S., Arava, S.K., Kabra, S.K.
Journal: Clinical Genetics
Year: 2024


📄 Quantitative and qualitative analysis of metallic ion release of orthodontic brackets in three different pH conditions - An invitro study
Authors: DA, P., Angel L, S., Chaudhari, P.K., Yadav, S.C., Duggal, R.
Journal: Journal of Oral Biology and Craniofacial Research
Year: 2024


📄 Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis
Authors: Gaur, P., Rajendran, Y., Srivastava, B., Ahuja, V., Srikanth, C.
Journal: eLife
Year: 2024


📄 Visual, rapid, and cost-effective BK virus detection system for renal transplanted patients using gold nanoparticle coupled loop-mediated isothermal amplification (nanoLAMP)
Authors: Kumar, S., Raman, S., Sesham, K., Mridha, A.R., Yadav, S.C.
Journal: Journal of Virological Methods
Year: 2024


 

Kercia Cruz | Agricultural and Biological Sciences | Best Researcher Award

Dr. Kercia Cruz | Agricultural and Biological Sciences | Best Researcher Award

Federal University of Bahia | Brazil

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Kercia Cruz began her academic journey with a degree in Biological Sciences from Universidade Federal da Bahia in 2014. She furthered her studies with a master’s in Biotechnology in Health and Investigative Medicine from Fundação Oswaldo Cruz, graduating in 2017. Her research during this period focused on leishmaniasis and the role of macrophages in infection. She then pursued a Ph.D. in Biotechnology in Health and Investigative Medicine at Fundação Oswaldo Cruz, completing it in 2023. Her doctoral research centered on the development of nanomedicines for treating leishmaniasis, particularly focusing on the protein translocator HSP90.

Professional Endeavors 🔬

Dr. Cruz has worked extensively in the field of general biology with a specialization in leishmaniasis and macrophage infections. Her professional experience includes positions at Universidade Federal da Bahia and Centro Universitário SENAI CIMATEC, where she has contributed significantly to research and education. Her roles involved working on projects related to the therapeutic potential of nanoparticles and the molecular mechanisms of leishmaniasis. She has also participated in various internships and short-term research activities across Brazil and Portugal. 🌍

Contributions and Research Focus 🧫

Dr. Cruz’s research primarily focuses on leishmaniasis, particularly the use of nanomedicines and the role of protein translocators like HSP90 in combating infection. She has been involved in several research projects exploring the potential of nanoparticle-based therapies for leishmaniasis and other infectious diseases. Her work also includes studying the molecular and cellular aspects of macrophage interactions with pathogens, contributing to the development of innovative treatment strategies. 🧪

Accolades and Recognition 🏅

Dr. Cruz has received notable recognition for her research contributions. In 2022, she was awarded an honorable mention for her work on polymeric nanoparticles containing amphotericin B at Embrapa. Additionally, she received a commendation in 2020 for her ongoing doctoral thesis from the Program of Postgraduate Studies in Biotechnology in Health and Investigative Medicine at Fiocruz. These accolades highlight her significant impact in her field. 🏆

Impact and Influence 🌟

Dr. Cruz’s research has advanced the understanding of leishmaniasis and the potential of nanomedicines in treating this disease. Her work on nanomedicine and protein translocators has provided valuable insights into innovative treatment approaches, potentially improving patient outcomes and contributing to global health solutions. Her contributions have influenced both academic research and practical applications in biotechnology. 🌐

Legacy and Future Contributions 🚀

Looking forward, Dr. Cruz aims to continue her work on developing novel therapeutic strategies for infectious diseases. Her future research will likely focus on expanding the use of nanomedicines and exploring new avenues in molecular biology to address pressing health challenges. Her dedication to advancing scientific knowledge and improving treatment options ensures that her legacy will continue to benefit the field of biotechnology and beyond.

 

Publications 📚


  • 📝Intraperitoneal Administration of 17-DMAG as an Effective Treatment against Leishmania braziliensis Infection in BALB/c Mice: A Preclinical Study
    • Authors: Kercia P. Cruz, Antonio L. O. A. Petersen, Marina F. Amorim, Alan G. S. F. Pinho, Luana C. Palma, Diana A. S. Dantas, Mariana R. G. Silveira, Carine S. A. Silva, Ana Luiza J. Cordeiro, Izabella G. Oliveira, Gabriella B. Pita, Bianca C. A. Souza, Gilberto C. Bomfim, Cláudia I. Brodskyn, Deborah B. M. Fraga, Isadora S. Lima, Maria B. R. De_Santana, Helena M. P. Teixeira, Juliana P. B. De_Menezes, Washington L. C. Santos
    • Journal: Pathogens
    • Year: 2024

  • 📝Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor
    • Authors: Kercia P. Cruz, Beatriz F. C. Patricio, Vinícius C. Pires, Marina F. Amorim, Alan G. S. F. Pinho, Helenita C. Quadros, Diana A. S. Dantas, Marcelo H. C. Chaves, Fabio R. Formiga, Helvécio V. A. Rocha, Patrícia S. T. Veras
    • Journal: Frontiers in Chemistry
    • Year: 2021

  • 📝Microbiologia no cotidiano: proposta de ensino por investigação de baixo custo
    • Authors: K. P. Cruz, G. L. Nery, A. A. D. Reboucás, P. R. Dantas-Silva, J. S. Cruz, C. G. S. Andrade, R. M. L. Rahimy
    • Journal: Atas de Ciências da Saúde
    • Year: 2019

  • 📝In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
    • Authors: C. E. S. Guedes, B. R. S. Dias, A. L. O. A. Petersen, Kercia P. Cruz, N. J. Almeida, D. R. Andrade, J. P. B. Menezes, V. M. Borges, P. S. T. Veras
    • Journal: Memórias do Instituto Oswaldo Cruz
    • Year: 2018

 

 

Nina Tuncel | Health Professions | Women Research Award

Assoc Prof Dr. Nina Tuncel | Health Professions | Women Research Award

Akdeniz University | Turkey

Author Profile

Scopus

Early Academic Pursuits

Assoc. Prof. Nina Tunçel began her academic journey with a solid foundation in physics at Al-Zahra University, Iran, where she completed her undergraduate studies from 1979 to 1987. She pursued postgraduate studies in Tıbbi Radyofizik  at Istanbul University's Health Sciences Institute from 1988 to 1991, followed by a doctoral degree in the same field from 1991 to 1998. Her academic pursuits in physics laid the groundwork for her interdisciplinary research focus encompassing medicine, health sciences, and biophysics.

Professional Endeavors

Throughout her career, Assoc. Prof. Nina Tunçel has held various academic and professional positions, demonstrating her commitment to advancing knowledge and expertise in her field. She began as a Research Assistant at Istanbul University's Onkoloji Enstitüsü (Oncology Institute) from 1993 to 1996, marking the beginning of her involvement in medical physics research. Subsequently, she held positions as an Expert at Akdeniz University's Faculty of Medicine and Dokuz Eylul University's Tıp Fakültesi (Faculty of Medicine) , where she contributed significantly to radiation oncology and internal medicine.

Contributions and Research Focus

Assoc. Prof. Tunçel's research areas span a wide range of disciplines, including medicine, health sciences, internal medicine sciences, radiation oncology, physics, and interdisciplinary physics. Her expertise in biophysics and medical physics has led to numerous contributions in the understanding and application of radiation in healthcare, such as the design of tissue-mimicking gel phantoms for diffusion kurtosis imaging and the optimization of radiotherapy techniques for various cancer treatments. Her research has been published in prestigious journals indexed by SCI, SSCI, and AHCI, highlighting her significant contributions to the scientific community.

Accolades and Recognition

Assoc. Prof. Nina Tunçel has received recognition for her outstanding contributions to the field of medical physics. Her research has earned her accolades such as the Best Researcher Award, demonstrating the impact of her work on advancing knowledge and innovation in healthcare. Additionally, she has been acknowledged for her academic excellence through publications in renowned journals and presentations at international conferences, further solidifying her reputation as a leading expert in her field.

Impact and Influence

Assoc. Prof. Tunçel's work has had a profound impact on the field of medical physics, particularly in the areas of radiation oncology and biophysics. Her research has contributed to the development of innovative techniques and methodologies for cancer treatment, improving the effectiveness and precision of radiation therapy while minimizing adverse effects on patients. Through her academic endeavors and professional contributions, she has inspired future generations of scientists and clinicians to explore new frontiers in medical physics and contribute to the advancement of healthcare.

Legacy and Future Contributions

Assoc. Prof. Nina Tunçel's legacy lies in her significant contributions to the field of medical physics, which have paved the way for advancements in cancer treatment and radiation therapy. Her research has provided invaluable insights into the complex interactions between radiation and biological systems, leading to improved patient outcomes and quality of life. As she continues her academic journey, Assoc. Prof. Tunçel remains committed to pushing the boundaries of knowledge in medical physics and shaping the future of healthcare through her innovative research and dedication to excellence.

Notable Publications

Physical and chemical properties of beads glasses 2023

Radio-sensitivity on MCF-7 cells of silver nanoparticles synthesized by Silybum marianum 2023 (3) 

Hybrid Tomo-Helical and Tomo-Direct radiotherapy for localized prostate cancer 2021 (1)

The dose rate measurements of C-arm fluoroscopic x-ray systems with and without apron 2018 (1)

Design and Characterisation of Tissue-Mimicking Gel Phantoms for Diffusion Kurtosis Imaging 2018 (17)

 

 

 

Miguel Angel Perez Rodriguez | Medicine and Dentistry | Editorial Board Member

Dr. Miguel Angel Perez Rodriguez | Medicine and Dentistry | Editorial Board Member

Hospital del Niño Poblano | Mexico

Author Profile

Orcid

Early Academic Pursuits

Dr. Miguel Angel Pérez Rodríguez embarked on his academic journey with a degree in physics from the National Autonomous University of Mexico (UNAM). His passion for healthcare led him to pursue a Master's Degree in Health Sciences from the National Polytechnic Institute, with ongoing studies in Health Services Management at the Swiss Institute.

Professional Endeavors

As a seasoned professional, Dr. Pérez Rodríguez holds key roles at the OTAE Clinic (Hospital Puebla) and the Hospital for the Puebla Child. His career includes diverse experiences, such as serving as an advisor at the Children's Hospital of Mexico and contributing to the state cochlear implant program. His private practice at the Cabinet of Audiology and Otoneurology of Puebla, Hospital Ángeles Puebla, reflects his commitment to healthcare.

Contributions and Research Focus

Dr. Pérez Rodríguez's impactful contributions extend to medical scientific publications, international journals, and national books. His research focuses on pediatric otological neurophysiology, central auditory processing disorder, and audiological findings in various patient groups. He holds certifications in Medical Genetics, Pediatric Audiology, and cochlear implant programming.

Accolades and Recognition

Being certified by the Mexican Council of Communication, Audiology, Otoneurology, and Phoniatrics, Dr. Pérez Rodríguez has earned recognition as Vice President of the Mexican Association of Communication, Audiology, Otoneurology, and Phoniatrics for 2023-2025.

Impact and Influence

His influence is evident in his roles as a high-specialty thesis advisor, editor of medical publications, and secretary of the state cochlear implant program. Dr. Pérez Rodríguez's work significantly impacts audiology and healthcare practices.

Legacy and Future Contributions

Dr. Pérez Rodríguez's legacy lies in his extensive research, publications, and contributions to audiology and healthcare in Mexico. As the current Vice President of the Mexican Association of Audiology, his future contributions are poised to further shape and advance the field.

Notable Publications

Vestibular and Balance Disorders in Mexican Children and Adolescents: Review of 8-Year Clinical Records 2021

ASSESSMENT OF CENTRAL AUDITORY PROCESSING DISORDER IN CHILDREN AND ADOLESCENTS TREATED WITH METHYLPHENIDATE DUE TO ATTENTION DEFICIT DISORDER: SYSTEMATIC REVIEW 2020

 

 

 

Aida Sarac Hadzihalilovic | Medicine and Dentistry | Best Researcher Award

Prof Dr. Aida Sarac Hadzihalilovic | Medicine and Dentistry | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits:

Aida Sarac-Hadzihalilovic commenced her academic journey with her Medical Doctor degree in 1995 from the Medical Faculty, University of Sarajevo. Subsequently, she pursued postgraduate studies in the fundamentals of medical research, culminating in a Master of Science (MSc) degree in 2002. Her dedication led her to earn a Doctoral (PhD) degree in 2006, presenting a thesis on "Quantitative analysis of the hippocampal formation and cognitive dysfunction in posttraumatic stress disorder."

Professional Endeavors:

Starting as an Assistant Lecturer in 1996, she taught anatomy to undergraduates studying medicine, nursing, dentistry, and psychology. Her academic progression led her to positions of increasing responsibility, including Senior Assistant Lecturer (2003-2008), Assistant Professor (2008-2016), and finally, achieving the rank of Full Professor in 2021, all within the Department of Anatomy, Medical Faculty, University of Sarajevo.

Contributions and Research Focus:

Professor Sarac-Hadzihalilovic's vast expertise lies in neuroanatomy and neuroscience, specifically focusing on volumetric brain analysis through structural MRI and the neuropsychological aspects of cognitive dysfunction. She conducted in-depth research on the limbic structures' volumetric analysis, notably the hippocampal formation and amygdala complex, correlating these findings with conditions like post-traumatic stress syndrome and temporal epilepsy. Moreover, her exploration extends to medical anthropology, applying it in skull typisation based on asymmetry, length, width, cephalic index, and cranial capacity, as well as gender skull dimorphism.

Accolades and Recognition:

Her remarkable contributions are evidenced by supervising numerous diploma papers, MSc and PhD students, post-doctoral research fellows, and active involvement in national and international research projects. Professor Sarac-Hadzihalilovic's publication record spans 49 research papers in peer-reviewed international and national journals, 44 contributions to national and international congresses and symposiums, and several authored books, emphasizing the significance of the skull's anatomical-anthropological aspects.

Impact and Influence:

Professor Sarac-Hadzihalilovic's influence transcends academia. She served on scientific committees, advisory boards, editorial boards of peer-reviewed international journals, and held roles as a visiting professor at various universities. Her impact extends to involvement in prestigious EU projects like COST – European Cooperation in Science and Technology, underlining her commitment to advancing research in neuroanatomy and medical anthropology.

Legacy and Future Contributions:

Her legacy lies in shaping the anatomical understanding of future medical professionals. Her continuous commitment to research, publication, and academic engagement promises continued advancements in neuroanatomy, neuroscience, and medical anthropology, enriching medical education and practice for generations to come.

Notable Publications

Radiographic Assessment in the Treatment of Supracondylar Humerus Fractures in Children 2012 (19)

Blood Vessels Distribution in Body and Tail of Pancreas- A Comparative Study of Age Related Variation 2010 (11)

DETERMINATION OF SEX BY DISCRIMINANT FUNCTION ANALYSIS OF LINEAR DIAMETERS IN BOSNIAN HUMAN SKULLS 2017 (4)

Bioanthropological analysis of human occipital condyles using geometric morphometric method 2020 (2)

Analysis of gender differences on pyriform aperture of human skulls using geometric morphometric method 2021 (5)

 

 

Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

Dr. Sanita Maleskic Kapo | Medicine and Dentistry | Best Researcher Award

University of Sarajevo | Bosnia and Herzegovina

Author Profile

Google Scholar

Early Academic Pursuits

Sanita Maleskic Kapo began her academic journey at the University of Sarajevo, delving into Pharmacology, Clinical Pharmacology, and Toxicology, culminating in her medical doctorate. Her formative years as a general practitioner at the Primary Health Care Center in Bihać enriched her understanding of patient care and community health.

Professional Endeavors

Transitioning into academia, she embraced teaching roles at the Faculty of Medicine, Sarajevo. Starting as a teaching assistant, her dedication and expertise elevated her to the position of Senior Teaching Assistant. Simultaneously, she embarked on a journey towards a Ph.D. in Pharmacology, further deepening her scholarly pursuits. Additionally, her ongoing residency in Clinical Pharmacology amplifies her practical acumen in the field.

Contributions and Research Focus

Sanita's contributions extend across academia and clinical practice. Her research focus in Pharmacology and Clinical Toxicology underscores her commitment to advancing medical knowledge. This commitment is reflected in her concurrent pursuit of a Ph.D. and residency, showcasing a dedication to scholarly and practical excellence.

Accolades and Recognition

Sanita Maleskic Kapo's journey is enriched by her notable accomplishments and dedication, marking her as a standout professional. While specific accolades may not be explicitly outlined, her multifaceted roles and continued academic progression underscore her recognition within the academic and medical spheres.

Impact and Influence

Her impact resonates through her teaching engagements, shaping future medical professionals. Simultaneously, her research endeavors lay the groundwork for advancements in Pharmacology and Clinical Toxicology, potentially influencing medical practices and patient care.

Legacy and Future Contributions

Sanita's legacy lies in her multifaceted contributions to academia, clinical research, and patient care. Her continued pursuit of a Ph.D. and residency promises a future where her expertise will further illuminate the realms of Pharmacology and Clinical Toxicology, potentially leaving an indelible mark in the field.

Notable Publications

Metformin use associated with protective effects for ocular complications in patients with type 2 diabetes - observational study 2017 (27)

Bioanthropological analysis of human occipital condyles using geometric morphometric method 2020 (5)

Analysis of gender differences on pyriform aperture of human skulls using geometric morphometric method 2021 (5)

Effects of topically applied diclofenac and ketoprofen on prostaglandin E2 and Stat3 sera levels and body temperature in two different acute inflammation models in rats 2021 (2)

Evaluation of long-term efficacy of disease-modifying agents in patients with relapsing-remitting multiple sclerosis 2019 (1)